Molecule Details
| InChIKey | MKGYPBDRQKFJKZ-VWLOTQADSA-N |
|---|---|
| Compound Name | 4-(2-{4-[(2S)-6-bromo-12,13-dichloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl]piperazin-1-yl}-2-oxoethyl)-1-oxidopyridin-1-ium |
| Canonical SMILES | O=C(Cc1cc[n+]([O-])cc1)N1CCN([C@H]2c3ccc(Cl)c(Cl)c3CCc3cc(Br)cnc32)CC1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.74 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile